期刊文献+

SD大鼠2型糖尿病模型的建立 被引量:62

Establishment of a Type 2 Diabetes Rat Model
下载PDF
导出
摘要 目的建立SD大鼠2型糖尿病模型。方法选SD大鼠,先喂以高脂高果糖饲料4周,导致胰岛素抵抗,继以小剂量链脲佐菌素(STZ)(30 mg/kg)腹腔注射1次,2周后诱导建立2型糖尿病模型。结果高糖高脂饮食后4周,大鼠出现胰岛素抵抗和高脂血症。注射STZ后,大鼠血糖,血胰岛素升高,胰岛素敏感性下降。结论本实验为糖尿病的实验研究提供了一种理想的动物模型。 Objective To set up a type 2 diabetes mellitus SD rat model, Methods SD rats were fed on a diet enriched in fat and fructose for 4 weeks to induce insulin resistance. The rats were injected intrapertonea[ly with a low-dose streptozoein (STZ) once (30 mg/kg) to induce hyperglycemia after 2 weeks, Resnlts Insulin sensitivity index was decreased significantly in control group and hypertension was seen after rats were fed on a diet enriched in fat and fructose. There were hyperglycemia, fast blood insulin increased and lower insulin sensitivity in rat models after STZ injection. Conclusion The experiment test provided an ideal type 2 diabetes mellitus SD rats model.
出处 《中国比较医学杂志》 CAS 2005年第6期379-381,共3页 Chinese Journal of Comparative Medicine
基金 安徽省教育厅自然科学基金资助(2003kj244)
关键词 糖尿病 非胰岛素依赖型 链脲佐菌素 果糖 大鼠 Diabetes mellitus Non-insulin-dependent Streptozocin Fructose Rats
  • 相关文献

参考文献7

  • 1第十七届国际糖尿病大会简介.中华糖尿病杂志,2001,9(1):60-62.
  • 2杨明功.糖尿病流行现状及防治对策[J].疾病控制杂志,2000,4(3):193-196. 被引量:71
  • 3周敏.实验性2型糖尿病动物模型研究及其进展[J].浙江中医学院学报,2001,25(5):79-80. 被引量:27
  • 4傅祖植,傅茂.肥胖和2型糖尿病[J].辽宁实用糖尿病杂志,2001,9(2):1-3. 被引量:34
  • 5徐叔云.临床用药指南[M].安徽:安徽科学技术出版社,1997.1124.
  • 6Avaroni I,Sander S,Scott S,et al,Effect of fructose feeding on insulin secretion and insulin action in the rat[J].Metabolism,1980,29:970.
  • 7Torburn AW,Storlicn LH,Jenkins AB,et al,Association between fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats[J],Am J Clin Nutr,1989,49:1155.

二级参考文献24

  • 1李秀钧 齐今吾.UKPDS简介与评价[J].实用糖尿病杂志,1999,(3):2-2.
  • 2李秀钧 刘国良.第16届国际糖尿病联盟会议纪要[J].实用糖尿病杂志,1997,3(5):2-2.
  • 3[1]Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in woman. Ann Intern Med 1995, 122:481~486.
  • 4[2]Boden G. Role of fatty aids in the pathogenesis of insulin resistance and NIDDM.Diabetes 1997,46:3~10.
  • 5[3]Hota misligil - GS, Budavari A, Murray D, et al. Reduce tyrosine kinase activity of the insulin receptor in obesity - diabetes. Central role of tumor necrosis factor α. J Clin Invest 1994, 94:1543~ 1549.
  • 6[4]Wang CN, O' Brindley L, Brindley DN. Effect of cell permeable ceramides and tumor necrosis factor α on insulin signaling and glucose uptake in 373 - LI adipocytes. Diabetes 1998,47:24~31.
  • 7[5]Kersten S, Desvergne B, Wahli W. Role of PPARs in health and disease. Nature 2000, 405: 421~ 424.
  • 8蔡文就,熊曼琪,朱章志,林安钟,郑高飞,贾可亮,陈芝喜,沈穗婷,何敏.实验性NIDDM大鼠模型及其胰岛素抵抗的初步研究[J].广州中医药大学学报,1997,14(2):87-91. 被引量:48
  • 9杨明功.提高对糖尿病的认识 [J].基层实用医学,2000,5(2):69-69.
  • 10 American Diabetes Association. Report of the Expert Committee on the diagnosis and classifacation of Diabetes Mellitus [J]. Diabetes Care, 1997,20:1183.

共引文献137

同被引文献602

引证文献62

二级引证文献546

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部